Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
1998

Early Stem Cell Transplantation for Chronic Lymphocytic Leukaemia

Sample size: 18 publication Evidence: moderate

Author Information

Author(s): P Dreger, N von Neuhoff, R Kuse, R Sonnen, B Glass, L Uharek, R Schoch, H Loffler, N Schmitz

Primary Institution: Second Department of Medicine, University of Kiel

Hypothesis

Can early stem cell transplantation improve the prognosis for patients with chronic lymphocytic leukaemia?

Conclusion

Sequential high-dose therapy using Dexa-BEAM and autologous stem cell transplantation is a safe and highly effective treatment for patients with chronic lymphocytic leukaemia.

Supporting Evidence

  • 16 out of 18 patients achieved minimal disease after treatment.
  • All patients showed a clone-specific molecular marker.
  • Procedure-related deaths did not occur.

Takeaway

Doctors are trying a new way to treat a type of blood cancer called chronic lymphocytic leukaemia by using special cells from the patients' own blood to help them get better.

Methodology

Patients received Dexa-BEAM chemotherapy to mobilize stem cells, followed by high-dose therapy and stem cell reinfusion, with monitoring for minimal residual disease using PCR.

Limitations

The study had a small sample size and a short follow-up period.

Participant Demographics

Median age was 49 years, with 5 females and 13 males; included patients with early and advanced stages of the disease.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication